Phase 1 mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting now
All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials, every phase
9
Phase 1 recruiting
Other phases for mCRPC (Metastatic Castration-resistant Prostate Cancer)
Phase 1 mCRPC (Metastatic Castration-resistant Prostate Cancer) trials
- A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- A Study of MHB048C in Patients With Advanced Solid Tumors
- A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
- Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.